US Dollar vs Yen

ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

登録

ホーム
投資
株式
アメリカ
NYSE
Teva Pharmaceutical Industries Ltd (TEVA)
Teva Pharmaceutical Industries Ltd (TEVA) ニュース

TEVA

Teva Pharmaceutical Indu... (TEVA)

Teva Pharmaceutical Industries Ltd

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NYSE:TEVA

<< 前へ 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2022/05/25	21 : 01	Edgar (US Regulatory)	Specialized Disclosure Report (sd)	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2022/05/23	21 : 00	Business Wire	Teva Presents New Long-Term AUSTEDO® (deutetrabenazine) Tablets Data at 2022 American Psychiatric Association Annual Meeting	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2022/05/19	20 : 32	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2022/05/18	07 : 26	Business Wire	Première licence accordée au Royaume-Uni pour le biosimilaire ophtalmologique de Teva, Ongavia (ranibizumab)▼	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2022/05/18	04 : 02	Business Wire	Großbritannien erteilt als erstes Land eine Zulassung für das ophthalmologische Biosimilar Ongavia (Ranibizumab) von Teva▼	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2022/05/17	22 : 10	Business Wire	United Kingdom first to grant licence for Teva’s ophthalmology biosimilar Ongavia (ranibizumab)▼	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2022/05/17	21 : 00	Business Wire	Teva to Present Latest Research From Neurology Portfolio at the 2022 American Psychiatric Association Annual Meeting	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2022/05/17	20 : 45	Business Wire	Teva Announces New Findings Highlighting Potential of ProAir® Digihaler® (albuterol sulfate) Inhalation Powder to Address Asthma Treatment Challenges	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2022/05/12	21 : 00	Business Wire	Teva to Present Findings on Short-Acting Beta Agonist (SABA) Use in Asthma Patients and the Potential of ProAir® Digihaler® (albuterol sulfate) Inhalation Powder to Help Inform Treatment Decisions at American Thoracic Society 2022 Annual Meeting	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2022/05/10	21 : 00	Business Wire	Teva Publishes 2021 ESG Progress Report, Showcasing Further Integration of ESG Into Business, Robust Targets and Strengthened ESG Governance Structure	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2022/05/04	05 : 08	Edgar (US Regulatory)	Quarterly Report (10-q)	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2022/05/03	20 : 00	Business Wire	Teva Reports First Quarter 2022 Financial Results	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2022/05/02	21 : 00	Business Wire	Teva Announces Settlement with Lupin Resolving AUSTEDO® (deutetrabenazine) Patent Dispute	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2022/04/20	21 : 54	TipRanks	Teva Hits FDA Hurdle, Slips 4.5% Pre-Market	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2022/04/20	07 : 10	Dow Jones News	Teva Pharmaceutical Industries Shares Retreat After FDA Rejection Letter	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2022/04/20	06 : 15	Business Wire	Teva and MedinCell Receive Complete Response Letter for TV-46000/mdc-IRM	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2022/04/05	20 : 34	PR Newswire (Canada)	Teva Canada Charts a New Prescription for Care	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2022/04/05	05 : 05	Business Wire	Teva to Host Conference Call to Discuss First Quarter 2022 Financial Results at 8 a.m. ET on May 3, 2022	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2022/04/01	21 : 00	Business Wire	Teva to Present New Analyses of AJOVY® (fremanezumab-vfrm) Injection and AUSTEDO® (deutetrabenazine) Tablets at 2022 American Academy of Neurology Annual Meeting	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2022/04/01	00 : 58	TipRanks	Teva Gains 6.4% on Another Opioid Case Settlement	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2022/03/30	22 : 55	Dow Jones News	Teva in Agreement With Florida to Settle Opioid-Related Claims	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2022/03/30	22 : 09	Business Wire	Teva Reaches Agreement With Florida to Settle the State’s Opioid-Related Claims	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2022/03/22	20 : 47	TipRanks	Teva Settles Opioid Case with Rhode Island, Aims National Settlement	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2022/03/22	04 : 45	Dow Jones News	Teva Pharmaceuticals Agrees to Pay Rhode Island $21 Million, Provide Opioid Treatment Options	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2022/03/22	03 : 55	Business Wire	Teva Reaches Agreement With Rhode Island to Settle Opioid-Related Claims	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2022/03/16	05 : 03	Edgar (US Regulatory)	Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2022/03/09	06 : 14	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2022/03/09	06 : 13	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2022/03/09	06 : 12	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
2022/03/09	06 : 11	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:TEVA	Teva Pharmaceutical Industries Ltd

Showing the most relevant articles for your search:NYSE:TEVA

<< 前へ 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 次へ >>

NLBNPIT1THV2 20241220 220

BNP Paribas Issuance

Vontobel Financial Produ...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約